LexAurum Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
14,186
+181
+1% +$4.74K 0.04% 317
2026
Q1
$393K Buy
+14,005
New +$373K 0.05% 272
2025
Q3
$370K Sell
14,525
-935
-6% -$23.1K 0.05% 259
2025
Q2
$375K Sell
15,460
-11,269
-42% -$263K 0.06% 236
2025
Q1
$677K Sell
26,729
-1,383
-5% -$36.2K 0.13% 147
2024
Q4
$746K Buy
28,112
+1,326
+5% +$36K 0.15% 130
2024
Q3
$775K Buy
26,786
+14,200
+113% +$414K 0.17% 116
2024
Q2
$352K Buy
12,586
+390
+3% +$10.7K 0.09% 202
2024
Q1
$338K Buy
12,196
+1,577
+15% +$43.8K 0.09% 205
2023
Q4
$306K Sell
10,619
-357
-3% -$10.8K 0.08% 222
2023
Q3
$364K Sell
10,976
-4,041
-27% -$143K 0.11% 183
2023
Q2
$551K Buy
15,017
+3,780
+34% +$147K 0.17% 119
2023
Q1
$458K Sell
11,237
-389
-3% -$16.8K 0.15% 132
2022
Q4
$596K Buy
11,626
+259
+2% +$12.4K 0.21% 104
2022
Q3
$497K Buy
11,367
+91
+0.8% +$4.42K 0.19% 115
2022
Q2
$591K Sell
11,276
-495
-4% -$25.2K 0.22% 99
2022
Q1
$609K Sell
11,771
-1,145
-9% -$59.4K 0.2% 109
2021
Q4
$763K Sell
12,916
-229
-2% -$11.3K 0.25% 85
2021
Q3
$565K Sell
13,145
-71
-0.5% -$3.15K 0.17% 152
2021
Q2
$518K Buy
13,216
+2,470
+23% +$96.1K 0.15% 158
2021
Q1
$389K Buy
10,746
+462
+4% +$16.4K 0.13% 166
2020
Q4
$379K Sell
10,284
-488
-5% -$17.9K 0.14% 162
2020
Q3
$375K Buy
10,772
+900
+9% +$31.6K 0.15% 138
2020
Q2
$306K Buy
9,872
+59
+0.6% +$2K 0.17% 135
2020
Q1
$304K Buy
9,813
+1,068
+12% +$36.4K 0.21% 108
2019
Q4
$325K Buy
8,745
+803
+10% +$28.6K 0.16% 145
2019
Q3
$271K Buy
7,942
+3
+0% +$109 0.16% 143
2019
Q2
$326K Sell
7,939
-9
-0.1% -$357 0.2% 117
2019
Q1
$320K Buy
7,948
+477
+6% +$19.1K 0.21% 109
2018
Q4
$309K Buy
7,471
+15
+0.2% +$623 0.24% 93
2018
Q3
$312K Sell
7,456
-412
-5% -$15.9K 0.22% 103
2018
Q2
$271K Buy
7,868
+3
+0% +$103 0.24% 101
2018
Q1
$265K Sell
7,865
-1,247
-14% -$42.9K 0.22% 110
2017
Q4
$316K Buy
+9,112
New +$311K 0.3% 93

Other funds holding PFE